Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)

Background: Despite the availability of an effective vaccine since the 1970s, rubella disease and, importantly, congenital rubella syndrome (CRS) remain a public health concern. The aim of this study was to analyze the rubella seroprevalence in the children population of the province of Florence and...

Full description

Bibliographic Details
Main Authors: Beatrice Zanella, Sara Boccalini, Benedetta Bonito, Marco Del Riccio, Federico Manzi, Emilia Tiscione, Paolo Bonanni, Working Group DHS, Working Group AOUMeyer, Working Group AUSLTC, Angela Bechini
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/8/4/599
_version_ 1797551243278680064
author Beatrice Zanella
Sara Boccalini
Benedetta Bonito
Marco Del Riccio
Federico Manzi
Emilia Tiscione
Paolo Bonanni
Working Group DHS
Working Group AOUMeyer
Working Group AUSLTC
Angela Bechini
author_facet Beatrice Zanella
Sara Boccalini
Benedetta Bonito
Marco Del Riccio
Federico Manzi
Emilia Tiscione
Paolo Bonanni
Working Group DHS
Working Group AOUMeyer
Working Group AUSLTC
Angela Bechini
author_sort Beatrice Zanella
collection DOAJ
description Background: Despite the availability of an effective vaccine since the 1970s, rubella disease and, importantly, congenital rubella syndrome (CRS) remain a public health concern. The aim of this study was to analyze the rubella seroprevalence in the children population of the province of Florence and compare the obtained results to a previous survey conducted in 2005–2006. Methods: A qualitative measurement of anti-rubella antibodies was performed on 165 sera using the enzyme-linked immunosorbent Assay (ELISA). The anamnestic and vaccination status was also collected. Results: Our study highlighted a very high rubella seroprevalence (85–100%) in our enrolled population. In the vaccinated group (153/165), 98.7% of them were positive to rubella antibodies. Conclusions: Our study showed the highest seroprevalence rate reached in the province of Florence for rubella in the last 15 years, thanks to the several successful vaccination campaigns promoted in the Tuscany region. Our findings in pediatric and adolescent subjects are a key factor in preventing CRS in adult life, specifically in childbearing women. Thus, the set goal will be to keep the awareness about the vaccination for this preventable disease high.
first_indexed 2024-03-10T15:41:48Z
format Article
id doaj.art-ce3f86927f5d448cae51a93a65b380ec
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T15:41:48Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-ce3f86927f5d448cae51a93a65b380ec2023-11-20T16:46:57ZengMDPI AGVaccines2076-393X2020-10-018459910.3390/vaccines8040599Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)Beatrice Zanella0Sara Boccalini1Benedetta Bonito2Marco Del Riccio3Federico Manzi4Emilia Tiscione5Paolo Bonanni6Working Group DHS7Working Group AOUMeyer8Working Group AUSLTC 9Angela Bechini10Department of Health Sciences, University of Florence, 50134 Florence, ItalyDepartment of Health Sciences, University of Florence, 50134 Florence, ItalyDepartment of Health Sciences, University of Florence, 50134 Florence, ItalyMedical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, ItalyMedical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, ItalyDepartment of Health Sciences, University of Florence, 50134 Florence, ItalyDepartment of Health Sciences, University of Florence, 50134 Florence, ItalyMedical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, ItalyMeyer Children’s Hospital, 50139 Florence, ItalyAUSL Toscana Centro, 50122 Florence, ItalyDepartment of Health Sciences, University of Florence, 50134 Florence, ItalyBackground: Despite the availability of an effective vaccine since the 1970s, rubella disease and, importantly, congenital rubella syndrome (CRS) remain a public health concern. The aim of this study was to analyze the rubella seroprevalence in the children population of the province of Florence and compare the obtained results to a previous survey conducted in 2005–2006. Methods: A qualitative measurement of anti-rubella antibodies was performed on 165 sera using the enzyme-linked immunosorbent Assay (ELISA). The anamnestic and vaccination status was also collected. Results: Our study highlighted a very high rubella seroprevalence (85–100%) in our enrolled population. In the vaccinated group (153/165), 98.7% of them were positive to rubella antibodies. Conclusions: Our study showed the highest seroprevalence rate reached in the province of Florence for rubella in the last 15 years, thanks to the several successful vaccination campaigns promoted in the Tuscany region. Our findings in pediatric and adolescent subjects are a key factor in preventing CRS in adult life, specifically in childbearing women. Thus, the set goal will be to keep the awareness about the vaccination for this preventable disease high.https://www.mdpi.com/2076-393X/8/4/599rubellaCRSvaccination coveragepediatricadolescentseroprevalence
spellingShingle Beatrice Zanella
Sara Boccalini
Benedetta Bonito
Marco Del Riccio
Federico Manzi
Emilia Tiscione
Paolo Bonanni
Working Group DHS
Working Group AOUMeyer
Working Group AUSLTC
Angela Bechini
Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)
Vaccines
rubella
CRS
vaccination coverage
pediatric
adolescent
seroprevalence
title Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)
title_full Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)
title_fullStr Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)
title_full_unstemmed Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)
title_short Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS)
title_sort rubella seroprevalence boost in the pediatric and adolescent population of florence italy as a preventive strategy for congenital rubella syndrome crs
topic rubella
CRS
vaccination coverage
pediatric
adolescent
seroprevalence
url https://www.mdpi.com/2076-393X/8/4/599
work_keys_str_mv AT beatricezanella rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT saraboccalini rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT benedettabonito rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT marcodelriccio rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT federicomanzi rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT emiliatiscione rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT paolobonanni rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT workinggroupdhs rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT workinggroupaoumeyer rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT workinggroupausltc rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs
AT angelabechini rubellaseroprevalenceboostinthepediatricandadolescentpopulationofflorenceitalyasapreventivestrategyforcongenitalrubellasyndromecrs